Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...

FOR IMMEDIATE RELEASE Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic ...

The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will combine Spineart and eCential Robotics’ robotic-assisted spine ...

Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiorityGeneva, March 11, 2025 – Spineart, a fast-growing company in ...

Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its Refine study on lumbar interlaminar fusion. 2. Interim data on Spineart’s ...

Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study ...

Geneva, March 11, 2025 - Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study, which ...